Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 353
Filtrar
2.
Mol Biol Cell ; 32(22)2021 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-34793240

RESUMO

It's been 50 years since Women in Cell Biology (WICB) was founded by junior women cell biologists who found themselves neither represented at the American Society for Cell Biology (ASCB) presentations nor receiving the information, mentoring, and sponsorship they needed to advance their careers. Since then, gender parity at ASCB has made significant strides: WICB has become a standing ASCB committee, women are regularly elected president of the ASCB, and half the symposia speakers are women. Many of WICB's pioneering initiatives for professional development, including career panels, workshops, awards for accomplishments in science and mentoring, and career mentoring roundtables, have been incorporated and adapted into broader "professional development" that benefits all members of ASCB. The time has passed when we can assume that all women benefit equally from progress. By strategically, thoughtfully, and honestly recognizing the challenges to women of the past and today, we may anticipate those new challenges that will arise in the next 50 years. WICB, in collaboration with the ASCB, can lead in data collection and access and can promote diversity, equity, and inclusion. This work will be a fitting homage to the women who, half a century ago, posted bathroom stall invitations to the first Women in Cell Biology meetup.


Assuntos
Biologia Celular , Sociedades Científicas , Congressos como Assunto , Feminino , Feminismo , História do Século XX , História do Século XXI , Humanos , Sociedades Científicas/história , Sociedades Científicas/tendências , Estados Unidos
3.
J Neuroimmune Pharmacol ; 16(3): 519-530, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34181181

RESUMO

This brief report collects the program and abstracts of the Society on NeuroImmune Pharmacology (SNIP) COVID-19 Virtual Workshop held on April 9, 2021. The workshop consisted of four symposia: Symposium 1: Molecular approaches to COVID-19 pathogenesis and underlying mechanisms; Symposium 2: Therapeutic and vaccine approaches to COVID-19; Symposium 3: Early Career Investigator talks; and Symposium 4: Diversity and Inclusion SNIP Committee (DISC) program: Well-being and reflections. The workshop also featured four special talks on COVID-19 and funding opportunities from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); COVID-19 and funding opportunities from the National Institute on Drug Abuse (NIDA); opportunities from NIH for early career investigator (ECI) fellows; and neurologic and psychiatric complications of SARS-CoV-2 infection. Presenters included NIH officials, SNIP members, and non-member scientists whose abstracts were submitted and accepted for inclusion in the virtual event hosted by the University of Nebraska Medical Center via Zoom webinar. A special theme issue of SNIP's official journal, the Journal of Neuroimmune Pharmacology (JNIP), will collect select papers from the workshop along with other related manuscripts in a special theme issue titled "Neuroimmune Pharmacology of SARS-CoV-2."


Assuntos
Tratamento Farmacológico da COVID-19 , COVID-19/imunologia , Educação/tendências , Neuroimunomodulação/imunologia , Sociedades Científicas/tendências , Antivirais/administração & dosagem , Antivirais/imunologia , Educação/métodos , Humanos , Fatores Imunológicos/administração & dosagem , Fatores Imunológicos/imunologia , Neuroimunomodulação/efeitos dos fármacos
4.
Fly (Austin) ; 15(1): 45-46, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-33618625
6.
Neuroimage ; 229: 117742, 2021 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-33454405

RESUMO

Scientific research aims to bring forward innovative ideas and constantly challenges existing knowledge structures and stereotypes. However, women, ethnic and cultural minorities, as well as individuals with disabilities, are systematically discriminated against or even excluded from promotions, publications, and general visibility. A more diverse workforce is more productive, and thus discrimination has a negative impact on science and the wider society, as well as on the education, careers, and well-being of individuals who are discriminated against. Moreover, the lack of diversity at scientific gatherings can lead to micro-aggressions or harassment, making such meetings unpleasant, or even unsafe environments for early career and underrepresented scientists. At the Organization for Human Brain Mapping (OHBM), we recognized the need for promoting underrepresented scientists and creating diverse role models in the field of neuroimaging. To foster this, the OHBM has created a Diversity and Inclusivity Committee (DIC). In this article, we review the composition and activities of the DIC that have promoted diversity within OHBM, in order to inspire other organizations to implement similar initiatives. Activities of the committee over the past four years have included (a) creating a code of conduct, (b) providing diversity and inclusivity education for OHBM members, (c) organizing interviews and symposia on diversity issues, and (d) organizing family-friendly activities and providing childcare grants during the OHBM annual meetings. We strongly believe that these activities have brought positive change within the wider OHBM community, improving inclusivity and fostering diversity while promoting rigorous, ground-breaking science. These positive changes could not have been so rapidly implemented without the enthusiastic support from the leadership, including OHBM Council and Program Committee, and the OHBM Special Interest Groups (SIGs), namely the Open Science, Student and Postdoc, and Brain-Art SIGs. Nevertheless, there remains ample room for improvement, in all areas, and even more so in the area of targeted attempts to increase inclusivity for women, individuals with disabilities, members of the LGBTQ+ community, racial/ethnic minorities, and individuals of lower socioeconomic status or from low and middle-income countries. Here, we present an overview of the DIC's composition, its activities, future directions and challenges. Our goal is to share our experiences with a wider audience to provide information to other organizations and institutions wishing to implement similar comprehensive diversity initiatives. We propose that scientific organizations can push the boundaries of scientific progress only by moving beyond existing power structures and by integrating principles of equity and inclusivity in their core values.


Assuntos
Centros Médicos Acadêmicos/métodos , Mapeamento Encefálico/métodos , Diversidade Cultural , Preconceito/etnologia , Preconceito/prevenção & controle , Sociedades Científicas , Centros Médicos Acadêmicos/tendências , Mapeamento Encefálico/tendências , Criatividade , Pessoas com Deficiência , Etnicidade , Humanos , Preconceito/psicologia , Sociedades Científicas/tendências
7.
Mol Biol Cell ; 31(23): 2495-2501, 2020 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-33119460

RESUMO

Scientific societies aiming to foster inclusion of scientists from underrepresented (UR) backgrounds among their membership often delegate primary responsibility for this goal to a diversity-focused committee. The National Science Foundation has funded the creation of the Alliance to Catalyze Change for Equity in STEM Success (ACCESS), a meta-organization bringing together representatives from several such STEM society committees to serve as a hub for a growing community of practice. Our goal is to coordinate efforts to advance inclusive practices by sharing experiences and making synergistic discoveries about what works. ACCESS has analyzed the approaches by which member societies have sought to ensure inclusivity through selection of annual meeting speakers. Here we discuss how inclusive speaker selection fosters better scientific environments for all and identify challenges and promising practices for societies striving to maximize inclusivity of speakers in their scientific programming.


Assuntos
Diversidade Cultural , Pesquisadores/ética , Sociedades Científicas/tendências , Demografia , Humanos , Sociedades Científicas/ética , Fala/ética
14.
J Invest Dermatol ; 140(9S): S197-S200, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32800177

RESUMO

To better understand and interpret the trends in cutaneous research, we carried out a network analysis of all the titles of the submitted abstracts of the annual meetings of the European Society of Dermatological Research (ESDR), including the International Investigative Dermatology (IID) meetings between 2010 and 2019. Network analysis is a data science tool to process, analyze, and visualize big sets of data. As expected, psoriasis was the frontrunner in each of the annual meetings, followed by dermatitis and melanoma. Interestingly, alopecia, acne, squamous cell carcinoma, pruritus, basal cell carcinoma, and hidradenitis suppurativa were among the next most frequently named diseases and/or terms. We also looked at diversity to assess how broad the interest of the submitting community is and to identify whether "blockbusters" such as psoriasis and atopic dermatitis expand in expense of other interests. In contrast to our expectations, the diversity of submissions to the ESDR annual meetings remained high over the 10 years of our observation period. Interestingly, the diversity increased in the years of the IID, indicating an outreach to other research areas worldwide compared with the ESDR meetings. This is true for both 2013 in Edinburgh, UK, and 2018 in Orlando, USA. During these meetings, this rise in diversity was associated with a relative decrease of the three most often named diseases. Network analysis thus may be a useful tool for research societies like the ESDR to identify trends and allocate resources such as reviewers and sessions accordingly. In addition, it can serve as quality control monitoring whether the ESDR continues to offer a platform for all researchers in cutaneous biology or implements or focuses on emerging fields.


Assuntos
Pesquisa Biomédica/tendências , Dermatologia/tendências , Editoração/tendências , Pesquisa Biomédica/história , Pesquisa Biomédica/organização & administração , Pesquisa Biomédica/estatística & dados numéricos , Congressos como Assunto/organização & administração , Congressos como Assunto/estatística & dados numéricos , Congressos como Assunto/tendências , Dermatologia/história , Dermatologia/organização & administração , Dermatologia/estatística & dados numéricos , Europa (Continente) , História do Século XXI , Humanos , Cooperação Internacional/história , Japão , Editoração/estatística & dados numéricos , Dermatopatias/diagnóstico , Dermatopatias/etiologia , Dermatopatias/terapia , Fenômenos Fisiológicos da Pele , Sociedades Científicas/história , Sociedades Científicas/estatística & dados numéricos , Sociedades Científicas/tendências , Estados Unidos
16.
BMJ ; 369: m1505, 2020 05 27.
Artigo em Inglês | MEDLINE | ID: mdl-32461201

RESUMO

OBJECTIVE: To investigate the nature and extent of financial relationships between leaders of influential professional medical associations in the United States and pharmaceutical and device companies. DESIGN: Cross sectional study. SETTING: Professional associations for the 10 costliest disease areas in the US according to the US Agency for Healthcare Research and Quality. Financial data for association leadership, 2017-19, were obtained from the Open Payments database. POPULATION: 328 leaders, such as board members, of 10 professional medical associations: American College of Cardiology, Orthopaedic Trauma Association, American Psychiatric Association, Endocrine Society, American College of Rheumatology, American Society of Clinical Oncology, American Thoracic Society, North American Spine Society, Infectious Diseases Society of America, and American College of Physicians. MAIN OUTCOME MEASURES: Proportion of leaders with financial ties to industry in the year of leadership, the four years before and the year after board membership, and the nature and extent of these financial relationships. RESULTS: 235 of 328 leaders (72%) had financial ties to industry. Among 293 leaders who were medical doctors or doctors of osteopathy, 235 (80%) had ties. Total payments for 2017-19 leadership were almost $130m (£103m; €119m), with a median amount for each leader of $31 805 (interquartile range $1157 to $254 272). General payments, including those for consultancy and hospitality, were $24.8m and research payments were $104.6m-predominantly payments to academic institutions with association leaders named as principle investigators. Variation was great among the associations: median amounts varied from $212 for the American Psychiatric Association leaders to $518 000 for the American Society of Clinical Oncology. CONCLUSIONS: Financial relationships between the leaders of influential US professional medical associations and industry are extensive, although with variation among the associations. The quantum of payments raises questions about independence and integrity, adding weight to calls for policy reform.


Assuntos
Conflito de Interesses/economia , Indústrias/economia , Médicos/economia , Sociedades Científicas/economia , Consultores/estatística & dados numéricos , Estudos Transversais , Indústria Farmacêutica/economia , Equipamentos e Provisões/economia , Humanos , Indústrias/ética , Indústrias/organização & administração , Liderança , Avaliação de Resultados em Cuidados de Saúde , Médicos/ética , Médicos/organização & administração , Sociedades Científicas/organização & administração , Sociedades Científicas/tendências , Estados Unidos/epidemiologia , United States Agency for Healthcare Research and Quality/organização & administração
17.
Artigo em Inglês | MEDLINE | ID: mdl-32247550

RESUMO

EEMS and its successor Society EEMGS have provided a dynamic and successful platform to stimulate research and exchanges among the different actors involved in the protection of the environment and of human health from exposure to genome stressors. It includes basic, translational and applied research projects. This was possible due to the enthusiasm, creativity and support of scientists convinced of the importance of these issues. In the future young scientists will take over with new questions, new challenges, new technologies, new discoveries and new applications. A major challenge is the ethical questions emerging from the impressive potential of present genetic technologies capable of impacting the evolution of nature and humankind. The EEMGS, where academics, regulators and industries meet, should play a central role in these aspects, in particular in support of primary prevention and the establishment of internationally recognized guidelines. Collaboration with colleagues and other teams are of great importance to establish a stimulating open dialogue on scientific questions. However the key issues remain to do careful and rigorous research; to use logic and background knowledge; to define adequate experimental designs; to provide transparency in the protocols; to check repeatability of the results and to combine several statistical approaches in the quest to get to the truth. Among the many challenges ahead, re-evaluation of some key fundamental questions is necessary, such as the interplay between genetics and epigenetics, the existence of specific germ cell mutagens or the identification of the mechanisms leading to mutagen induced diseases. Translational and applied research will further include the development of systemic biomonitoring protocols, if possible in a single biological sample, the redaction of internationally harmonized guidelines but also the organization of platforms between geneticists and physicians open to all actors in the field. The creation of an independent European center to assess risk from exposure to mutagens, in particular in the light of the problematic of global warming might be very helpful.


Assuntos
Monitoramento Ambiental , Genoma Humano/genética , Metagenômica/tendências , Mutagênese/genética , Pesquisa Biomédica/tendências , Europa (Continente) , Humanos , Sociedades Científicas/tendências
20.
Sch Psychol ; 35(6): 363-366, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33444049

RESUMO

This Special Issue celebrates the 75th anniversary of the formation of the Division of School Psychology of the American Psychological Association. As part of this milestone celebration, we envisioned a field that could be changed by transcending the past, excelling in the present, and transforming the future. We identified a seminal article written by Conoley and Gutkin (1995) that advocated for the implementation of a systemic, prevention-oriented, ecological framework that would allow school psychology to realize its promise. Conoley, Powers, and Gutkin (2020) provided a synopsis of progress and stagnation in a new paper that served as the nexus from which invited authors were asked to respond, each representing a different aspect of school psychology practice, science, and training. In light of the division anniversary, authors described the historical context of their domain, reflected on the present, and shared recommendations for the future of school psychology. Collectively these contributions discussed school psychology's achievement to date, identify its shortfalls, and offer actionable suggestions for future school psychologists. Transformation is critical now more than ever in light of current health and world concerns and school psychology training and practice issues related to social justice and psychological and educational change. School psychologists are called to become proactive agents of change if we are to help heal our fractured and wounded world. (PsycInfo Database Record (c) 2021 APA, all rights reserved).


Assuntos
Psicologia Clínica/tendências , Psicologia Educacional/tendências , Sociedades Científicas/tendências , Aniversários e Eventos Especiais , Prática Clínica Baseada em Evidências , Humanos , Competência Profissional , Psicologia Clínica/educação , Psicologia Educacional/educação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA